Formosa Laboratories, Inc., Taiwan
Formosa Laboratories - a product/project-related co-operation partner for Active Pharmaceutical Ingredients.
The Company:
Formosa Laboratories was founded in 1996 as a provider of contract R&D.
Following years of expansion, Formosa now produces high-quality APIs and advanced intermediates in its modern facilities conveniently located in suburban Taipei. With its GMP-compliance approved by the local authority and the US-FDA, Formosa sells its products throughout the world, including the US, Japan and Europe.
Custom synthesis from laboratory to commercial production is provided on confidential basis and its backed by years of experience in process development, validation and preparation of registration dossiers, including the US and EU DMFs.
Specific Strengths:
Formosa produces niche active pharmaceutical ingredients, e.g. Vitamin D derivatives with state-of-the-art technology under cGMP. The company provides custom synthesis from process development to commercial production with high efficiency and competitive pricing and is experienced in multi-step complicated synthesis.
The reaction capability includes:
- Alkylation
- Chiral resolution
- Diazotization
- Grignard reaction
- Heck reaction
- Catalytic hydrogenation
- Ozonolysis
- Reductive amination
- Wittig reaction
- Pyrolysis (up to 800 °C)
Further Valuable Information:
Formosa successfully passed the first Pre-Approval Inspection (PAI) by US-FDA in October 2004.
 |
 |
